Low-Level Light Therapy Downregulates Scalp Inflammatory Biomarkers in Men With Androgenetic Alopecia and Boosts Minoxidil 2% for Sustainable Hair Regrowth

    Yann Mahe, Ahsène Cheniti, Charlotte Tacheau, Rosaria Antonelli, Lien Planard-Luong, Simon de Bernard, Laurent Buffat, Philippe Barbarat, Leila Kanoun-Copy
    From the encyclopedia
    Low Level Laser Therapy →

    laser therapy for anti-inflammatory and likely insignificant hair regrowth effects

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Image
    Studysummary This study observed that adding low-level light therapy with the GentleWaves® device to Minoxidil significantly boosted hair regrowth in men with androgenetic alopecia by reducing scalp inflammation. Our plain-language summary of this paper — not a Tressless recommendation.
    The study investigated the potential benefit of low-level light therapy (LLLT) using visible to infrared light on scalp inflammation and hair regrowth activity in men with androgenetic alopecia (AGA). The study conducted a clinical trial on 64 men with AGA using LLLT/GentleWaves® and performed a whole-genome analysis of treated scalp biopsies. The results showed downregulation of scalp inflammatory biomarkers and the disappearance of CD69 mRNA in about 50% of the studied volunteers prior to the LLLT/GentleWaves® treatment. In the second clinical study, including 135 alopecic volunteers, LLLT/GentleWaves® was able to boost the hair regrowth activity of a Minoxidil 2% lotion to the extent of the highest concentration (5%) in terms of efficacy, number of responders, and perceived performance. The study suggests the potential benefit of LLLT/GentleWaves® as a non-invasive adjunctive technology for skin and scalp conditions, where a mild perifollicular inflammation is involved.
    Discuss this study in the Community →

    Research cited in this study

    21 / 21 results